Druva Recognized as a Global Leader in Cloud Computing with 2022 Stratus Award
The Latest Award Highlights Druva’s Unique SaaS-based Approach to Securing and Protecting Data SANTA CLARA,…
The Latest Award Highlights Druva’s Unique SaaS-based Approach to Securing and Protecting Data SANTA CLARA,…
SAN FRANCISCO–(BUSINESS WIRE)–#AndersenGlobal–Andersen Global strengthens its global presence in East Asia through a non-exclusive Collaboration…
Get half off when adding a line or with eligible trade-in BELLEVUE, Wash.–(BUSINESS WIRE)–Hold the…
Munich plugfest assembles MIPI I3C and I3C Basic implementers for initial to advanced interoperability testing…
Darrin brings over two decades of experience in finance and vision insurance to Versant Health…
BLOOMINGTON, Minn.–(BUSINESS WIRE)–SkyWater Technology (NASDAQ: SKYT), the trusted technology realization partner, today announced the Department…
Partner Program Offers New Rewards, Incentives and Certifications to Maximize Value for Partners; Jennifer Lee…
MINNEAPOLIS, September 27, 2022 – Perforce Software, a provider of solutions to enterprise teams requiring…
New Global Survey from Odaseva Also Finds that Only 50% of Organizations Impacted by an…
SAN DIEGO, Sept. 27, 2022 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
SAN DIEGO, Sept. 27, 2022 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
SAN DIEGO, Sept. 27, 2022 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
Bentrio USA Altamira Therapeutics Re-launches Bentrio in Europe for Allergic Rhinitis HAMILTON, BERMUDA , Sept….
Bentrio USA Altamira Therapeutics Re-launches Bentrio in Europe for Allergic Rhinitis HAMILTON, BERMUDA , Sept….
Bentrio USA Altamira Therapeutics Re-launches Bentrio in Europe for Allergic Rhinitis HAMILTON, BERMUDA , Sept….
LAWRENCEVILLE, N.J., Sept. 27, 2022 (GLOBE NEWSWIRE) — Imunon, Inc. (NASDAQ: IMNN), a clinical-stage drug development…
LAWRENCEVILLE, N.J., Sept. 27, 2022 (GLOBE NEWSWIRE) — Imunon, Inc. (NASDAQ: IMNN), a clinical-stage drug development…
LAWRENCEVILLE, N.J., Sept. 27, 2022 (GLOBE NEWSWIRE) — Imunon, Inc. (NASDAQ: IMNN), a clinical-stage drug development…
CAMBRIDGE, Mass., Sept. 27, 2022 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a…
CAMBRIDGE, Mass., Sept. 27, 2022 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a…